Summary
In a significant market movement during June 2016, F2G was the subject of a vc funding. The transaction achieved a gross valuation of £42,160,110. Leading the round was Advent Venture Partners, Sectoral Asset Management, Brace Pharma, Merifin Capital, Aisling Capital, S, Sunstone Capital, Novartis Venture Fund, Novo A.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Advent Venture Partners
Lead Investor / Acquirer
Sectoral Asset Management
Lead Investor / Acquirer
Brace Pharma
Lead Investor / Acquirer
Merifin Capital
Lead Investor / Acquirer
Aisling Capital
Lead Investor / Acquirer
S
Lead Investor / Acquirer
Sunstone Capital
Lead Investor / Acquirer
Novartis Venture Fund
Lead Investor / Acquirer
Novo A
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Growth prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in